ASCO releases updated breast RT guideline
The American Society of Clinical Oncology (ASCO) has released an updated guideline...Read more on AuntMinnie.comRelated Reading: New treatment guidelines issued for DCIS ASCO BCS: Breast MRI useful for average-risk women, too ASCO BCS research highlights benefits of mobile mammo, PET/MR ASTRO publishes guidelines for accelerated whole-breast RT IMRT reduces skin toxicity symptoms for breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 29, 2016 Category: Radiology Source Type: news

ASTRO: Radiation boost cuts local recurrence in DCIS patients
A supplemental boost of radiation cuts breast cancer recurrence in women with...Read more on AuntMinnie.comRelated Reading: New treatment guidelines issued for DCIS Needle biopsy hormone testing unnecessary for DCIS Delayed rad therapy puts women with DCIS at risk ASBrS: No, we're not overtreating DCIS New study to examine how to treat early breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 28, 2016 Category: Radiology Source Type: news

ASTRO: Outreach boosts radiation therapy rates for blacks
BOSTON - A patient outreach program essentially eliminated the treatment gap...Read more on AuntMinnie.comRelated Reading: ASNR 2016: Race and sex affect who gets brain imaging Delayed rad therapy puts women with DCIS at risk Socioeconomic factors affect patient care in radiology Racial discrepancies persist in breast cancer diagnoses (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2016 Category: Radiology Source Type: news

Young Age and DCIS Tied to Increased Risk of Breast Tumor Recurrence Young Age and DCIS Tied to Increased Risk of Breast Tumor Recurrence
In women ages 40 and younger, the presence of ductal carcinoma in situ (DCIS) next to an invasive tumor is associated with an increased risk of ipsilateral breast tumor recurrence (IBTR), according to a recently published study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 16, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

DCIS Score Fails Cost-Effectiveness Test DCIS Score Fails Cost-Effectiveness Test
The Oncotype DX DCIS Score was not cost-effective in any of five different treatment strategies that were analyzed.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 15, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Current Trends in the Management of Ductal Carcinoma In Situ
This review will summarize the current trends in the diagnosis and management of DCIS and will highlight ongoing trials that are shaping future management of this entity. (Source: CancerNetwork)
Source: CancerNetwork - September 15, 2016 Category: Cancer & Oncology Authors: E. Shelley Hwang, MD, MPH Tristen S. Park, MD Tags: Breast Cancer Oncology Journal Review Article Source Type: news

Common breast cancer test may not be worth the cost, UCLA study suggests
A genomic test widely used to help determine whether women with a common form of breast cancer should undergo radiation is not cost effective, according to a new UCLA Jonsson Comprehensive Cancer Center study. The Oncotype DX DCIS test is given to women with ductal carcinoma in situ, which means the cancer has not spread to any other tissues, to help them choose the best treatment by better identifying the potential of tumors to come back.Oncotype DX DCIS reduces the number of women undergoing radiation therapy, which is good because it decreases the number of women exposed to possibly harmful side effects. However, UCLA J...
Source: UCLA Newsroom: Health Sciences - September 13, 2016 Category: Universities & Medical Training Source Type: news

Presence of DCIS, Younger Age Affect Breast Cancer Recurrence Risk
The presence of DCIS adjacent to invasive breast tumor and a younger age at diagnosis are associated with increased risk of ipsilateral breast tumor recurrence. (Source: CancerNetwork)
Source: CancerNetwork - September 9, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Breast Cancer News Source Type: news

New Consensus Guidelines on DCIS Establish Ideal Surgical Margins
In this interview we discuss new consensus guidelines from ASCO, SSO, and ASTRO that establish 2 mm surgical margins for treating DCIS patients. (Source: CancerNetwork)
Source: CancerNetwork - September 7, 2016 Category: Cancer & Oncology Authors: Barbara L. Smith, MD, PhD Mary L. Gemignani, MD Tags: Breast Cancer Source Type: news

Guidelines matter for breast screening referrals
It seems like almost every medical specialty has its own guidelines for when...Read more on AuntMinnie.comRelated Reading: ACR backs bill to extend mammo screening coverage ASBrS: No, we're not overtreating DCIS ASBrS: 50% of women under 45 at elevated breast cancer risk Shop 'n' scan: Are department stores mammography's future? New study to tackle personalized breast screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 19, 2016 Category: Radiology Source Type: news

Guidelines Establish Minimum Negative Margins in DCIS
­Three medical organizations including ASCO have issued a guideline on margins in breast conserving surgery for patients with ductal carcinoma in situ. (Source: CancerNetwork)
Source: CancerNetwork - August 18, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Breast Cancer News Source Type: news

Guideline Supports 2-mm Margins for DCIS (CME/CE)
(MedPage Today) -- Wider not better at reducing recurrence risk (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 16, 2016 Category: Primary Care Source Type: news

New Guide on DCIS Margins: Bigger Not Always Better New Guide on DCIS Margins: Bigger Not Always Better
Three major organizations jointly define what is adequate with regard to the margin width of surgically removed DCIS tissue and have a surprise about size.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 16, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New treatment guidelines issued for DCIS
Three national cancer organizations on August 15 issued a consensus guideline...Read more on AuntMinnie.comRelated Reading: Needle biopsy hormone testing unnecessary for DCIS Delayed rad therapy puts women with DCIS at risk ASBrS: No, we're not overtreating DCIS Rates of high-grade DCIS increase with age Kopans: JAMA Oncology paper misinterprets DCIS data (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 15, 2016 Category: Radiology Source Type: news

New Guidelines Set Safe Surgery Margins for Some Breast Cancers
FRIDAY, Aug. 12, 2016 -- New surgery guidelines for certain breast cancer patients could reduce both unnecessary surgeries and recurrence rates, three U.S. cancer groups say. The guideline is for treatment of women with ductal carcinoma in situ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 15, 2016 Category: Journals (General) Source Type: news